Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.

Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MC.

Cost Eff Resour Alloc. 2012 Sep 19;10(1):12. doi: 10.1186/1478-7547-10-12.

PMID:
22992315
[PubMed]
Free PMC Article
2.

Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.

Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KA.

Antivir Ther. 2013;18(1):45-55. doi: 10.3851/IMP2231. Epub 2012 Jul 18.

PMID:
22809695
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.

Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP.

PLoS One. 2012;7(4):e36001. doi: 10.1371/journal.pone.0036001. Epub 2012 Apr 30.

PMID:
22558301
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group.

PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6.

PMID:
22412867
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.

Ouattara EN, Anglaret X, Wong AY, Chu J, Hsu HE, Danel C, Eholié S, Moh R, Gabillard D, Walensky RP, Freedberg KA.

AIDS. 2012 Mar 13;26(5):625-34. doi: 10.1097/QAD.0b013e328350fbfb.

PMID:
22398569
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group.

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4.

PMID:
22173233
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.

Lewden C, Gabillard D, Minga A, Ekouévi DK, Avit D, Konate I, Amani-Bossé C, Messou E, Coffie P, Ouedraogo A, Laurent C, Anglaret X; ANRS 12222 MorbidityMortality Study Group.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):213-9. doi: 10.1097/QAI.0b013e31823b837e.

PMID:
22027874
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters.

Minga AK, Lewden C, Gabillard D, Bomisso GI, Toni TD, Emième AA, Yapo V, Inwoley A, Salamon R, Anglaret X; Agence Nationale de Recherches sur le Sida (ANRS) 1220 Primo-CI Study Group.

AIDS. 2011 Mar 27;25(6):819-23. doi: 10.1097/QAD.0b013e32834625d3.

PMID:
21412060
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, Kouakou M, Danel C, Sloan C, Rouzioux C, Freedberg KA, Anglaret X.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):356-64. doi: 10.1097/QAI.0b013e3182084b5a.

PMID:
21191309
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.

Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, Losina E, Freedberg KA, Danel C, Anglaret X, Yazdanpanah Y.

PLoS One. 2010 Oct 15;5(10):e13414. doi: 10.1371/journal.pone.0013414.

PMID:
20976211
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Minga A, Lewden C, Dohoun L, Abo Y, Emieme A, Coulibaly A, Salamon R, Eholié S, Anglaret X, Danel C; ANRS 1220 Primo-CI Study Group.

AIDS Res Hum Retroviruses. 2010 Sep;26(9):991-5. doi: 10.1089/aid.2009.0309.

PMID:
20707728
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.

Yazdanpanah Y, Wolf LL, Anglaret X, Gabillard D, Walensky RP, Moh R, Danel C, Sloan CE, Losina E, Freedberg KA; CEPAC-International Investigators.

Antivir Ther. 2010;15(3):351-61. doi: 10.3851/IMP1542.

PMID:
20516555
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness.

Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA; CEPAC-International Investigators.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):258-68. doi: 10.1097/QAI.0b013e3181d0db97.

PMID:
20404739
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Low HIV testing rates among tuberculosis patients in Kampala, Uganda.

Sendagire I, Schreuder I, Mubiru M, van der Loeff MS, Cobelens F, Konde-Lule J.

BMC Public Health. 2010 Mar 31;10(1):177. doi: 10.1186/1471-2458-10-177.

PMID:
20356353
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators.

PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173. Epub 2009 Oct 27.

PMID:
19859538
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.

Korenromp EL, Williams BG, Schmid GP, Dye C.

PLoS One. 2009 Jun 17;4(6):e5950. doi: 10.1371/journal.pone.0005950.

PMID:
19536329
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies.

eligibility for ART in lower income countries (eART-linc) collaboration, Wandel S, Egger M, Rangsin R, Nelson KE, Costello C, Lewden C, Lutalo T, Ndyanabo A, Todd J, Van der Paal L, Minga A, Zwahlen M.

Sex Transm Infect. 2008 Aug;84 Suppl 1:i31-i36. doi: 10.1136/sti.2008.029793.

PMID:
18647863
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds.

Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE.

Sex Transm Infect. 2008 Aug;84 Suppl 1:i24-i30. doi: 10.1136/sti.2008.029868.

PMID:
18647862
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk